Skip to main content
OpenTrials
Completed

NCT Number: NCT00726245

Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Muscle Tear

Age range

15 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Meir Medicak Center

Kfar Saba, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • US diagnosed muscle tear
  • age 15-40 years old

Exclusion criteria

  • pregnancy
  • mental or physical disabilities

Treatment and study plan

PRGF

Biological

3-6mg IM (to area of muscle tear)

Placebo

Biological

3cc IM of physiological saline

Primary outcomes

  1. improvement of symptoms / disease progress

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Meir Medical Center

Other

Registry information

Official study title

PRP as a Treatment for Acute Muscle Tears - Randomized-double-blind-placebo Control Trail.

Important dates

Study start
2008
Primary completion
2009
Study completion
2011
First posted
Jul 31, 2008
Registry last updated
Jul 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.